Show
Sort by
-
GSDMD drives canonical inflammasome-induced neutrophil pyroptosis and is dispensable for NETosis
-
- Journal Article
- A1
- open access
Bacillus anthracis induces NLRP3 inflammasome activation and caspase-8-mediated apoptosis of macrophages to promote lethal anthrax
-
Nanoparticle-sensitized photoporation enables inflammasome activation studies in targeted single cells dagger
-
- Journal Article
- A1
- open access
MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
-
Structure of S-layer protein Sap reveals a mechanism for therapeutic intervention in anthrax
-
- Journal Article
- A1
- open access
Caspase-1 engagement and TLR-induced c-FLIP expression suppress ASC/caspase-8-dependent apoptosis by inflammasome sensors NLRP1b and NLRC4
-
Nlrp6-and ASC-dependent inflammasomes do not shape the commensal gut microbiota composition
-
Inflammasomes in inflammatory disease
(2016) EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. In European Journal of Clinical Investigation 46(Supplement 1). p.99-99 -
Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation
(2016) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 113(50). p.14384-14389 -
Neutralizing TNFα restores glucocorticoid sensitivity in a mouse model of neutrophilic airway inflammation
-
- Journal Article
- A1
- open access
Glucocorticoid-induced microRNA-511 protects against TNF by down-regulating TNFR1
-
Regulation and dysregulation of tumor necrosis factor receptor-1
-
Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation
-
- Journal Article
- A1
- open access
LPS resistance of SPRET/Ei mice is mediated by Gilz, encoded by the Tsc22d3 gene on the X chromosome
-
- Journal Article
- A1
- open access
Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF
-
- Journal Article
- A1
- open access
Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium
-
Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1
-
New strategies to prevent TNF-induced toxicity in TNF/IFNγ-based anti-tumor models
(2011) -
Endothelial outgrowth cells are not derived from CD133(+) cells or CD45(+) hematopoietic precursors